本篇論文以研究阿茲海默症為出發點，因為腦脊液的異常流動造成澱粉樣蛋白Aβ_42聚集導致阿茲海默疾病，全球數千萬老年人因此病在身，針對此疾病引起極大的關注。將微流道技術與生醫研究做結合，利用Polydimethylsiloxane把曝光微影製程來製作模型進行翻模，本身Polydimethylsiloxane為疏水性，透過將不同類型的微流道進行表面修飾，使表面改質達到親水性，能透過物理吸附提高蛋白沉澱效果，經由人造仿生流速結合Aβ的流動，進行傳遞，透過檢測觀察表面的變化，發現表面進行表面修飾後使Aβ抑制劑和Aβ蛋白起著接合作用，並提高了澱粉樣蛋白β留在組織上，分析不同微流道對聚集之影響。另外，使用了創新的表面修飾方法提高官能團化反應，也透過簡單的檢測儀器驗證表面修飾的存在。本論文主要是分析柱狀與平滑微流道的吸附差異，因為在柱狀微流通道中表面積減小，但接觸面積增加，使蛋白分子接觸提升，更能吸附在微流道內部。

In this study, takes the Alzheimer's disease as a starting point, because a abnormal flow of cerebrospinal fluid causes amyloid beta to cause Alzheimer's disease, which causes tens of millions of elderly people around the world to become get sick, it is of great concern. Combining microfluidic technology with biomedical techno-logy, using Polydimethylsiloxane to make a model with lithography process to rolling over, polydimethylsiloxane itself for hydrophobic, through the different types of microchannel with surface modification, so that surface modification to achieve hydrophilic, can improve the protein aggregat-ion effect by physical adsorption. Throu-gh the flow of artificial flow rate binding A-beta, use the instrument to detect and observe the surface condition, found that the surface modification of the surface to make A-beta inhibitors and A-beta protein have a joint effect, and improve the amyloid beta leave on the micro-channel, analyze the effects of different microchannel on aggregation.
In addition, the surface modification method integrate the microfluidic sys-tem to improve the functional group reaction. This study mainly analyzes the adsorption difference between column and smooth microchannel, because the surface area of the column is reduced, and the contact area increases, that A- beta protein contacts is enhanced, it can be more adsorbed inside the micro-channel.

1. Kemp, P., et al., Alzheimer’s disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia. Journal of Neurology, Neurosurgery & Psychiatry, 2003. 74(6): p. 715-719.
2. Alzheimer, A., The discovery of Alzheimer's disease. Dialogues Clin Neuroscience, 1906.
3. Berry, B.J., et al., Physiological Aβ concentrations produce a more biomimetic representation of the Alzheimer’s Disease phenotype in iPSC derived human neurons. ACS chemical neuroscience, 2018. 9(7): p. 1693-1701.
4. Vigo‐Pelfrey, C., et al., Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid. Journal of neurochemistry, 1993. 61(5): p. 1965-1968.
5. Motter, n., et al., Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 1995. 38(4): p. 643-648.
6. Heneka, M.T., et al., Neuroinflammation in Alzheimer's disease. The Lancet Neurology, 2015. 14(4): p. 388-405.
7. Brown, P., et al., Molecular mechanisms of cerebrospinal fluid production. Neuroscience, 2004. 129(4): p. 955-968.
8. Chen, G.-f., et al., Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacologica Sinica, 2017. 38(9): p. 1205-1235.
9. Gospodarczyk, W. and M. Kozak, Microchip Circulation Drastically Accelerates Amyloid Aggregation of 1–42 β-amyloid Peptide from Felis catus. ACS chemical neuroscience, 2017. 8(11): p. 2558-2567.
10. Lun, M.P., E.S. Monuki, and M.K. Lehtinen, Development and functions of the choroid plexus–cerebrospinal fluid system. Nature Reviews Neuroscience, 2015. 16(8): p. 445-457.
11. Ho, C.M. and Y.C. Tai, Micro-electro-mechanical-systems (MEMS) and fluid flows. Annual Review of Fluid Mechanics, 1998. 30: p. 579-612.
12. Lee, J.S. and C.B. Park, Microfluidic dissociation and clearance of Alzheimer’s β-amyloid aggregates. Biomaterials, 2010. 31(26): p. 6789-6795.
13. Devadhasan, J.P., S. Kim, and J. An, Fish-on-a-chip: a sensitive detection microfluidic system for alzheimer's disease. Journal of biomedical science, 2011. 18(1): p. 33.
14. Ren, Y., A. Kunze, and P. Renaud, Compartmentalized microfluidics for in vitro Alzheimer’s disease studies, in Microfluidic and compartmentalized platforms for neurobiological research. 2015, Springer. p. 197-215.
15. Mohamadi, R.M., et al., An integrated microfluidic chip for immunocapture, preconcentration and separation of β-amyloid peptides. Biomicrofluidics, 2015. 9(5): p. 054117.
16. Mai, T.D., et al., Single-step immunoassays and microfluidic droplet operation: towards a versatile approach for detection of amyloid-β peptide-based biomarkers of Alzheimer’s disease. Sensors and Actuators B: Chemical, 2018. 255: p. 2126-2135.
17. Gokaltun, A., et al., Recent advances in nonbiofouling PDMS surface modification strategies applicable to microfluidic technology. Technology, 2017. 5(01): p. 1-12.
18. Qiu, J., P. Hu, and R. Liang, Separation and simultaneous determination of uric acid and ascorbic acid on a dynamically modified poly (dimethylsiloxane) microchip. Analytical Sciences, 2007. 23(12): p. 1409-1414.
19. Sung, W.-C., et al., Functionalized 3D-hydrogel plugs covalently patterned inside hydrophilic poly (dimethylsiloxane) microchannels for flow-through immunoassays. Analytical chemistry, 2009. 81(19): p. 7967-7973.
20. Lee, S. and J. Vörös, An aqueous-based surface modification of poly (dimethylsiloxane) with poly (ethylene glycol) to prevent biofouling. Langmuir, 2005. 21(25): p. 11957-11962.
21. Xu, J. and K.K. Gleason, Conformal, amine-functionalized thin films by initiated chemical vapor deposition (iCVD) for hydrolytically stable microfluidic devices. Chemistry of Materials, 2010. 22(5): p. 1732-1738.
22. Xia, H., et al., Microfluidic based immunosensor for detection and purification of carbonylated proteins. Biomedical microdevices, 2013. 15(3): p. 519-530.
23. Gospodarczyk, W. and M. Kozak, The severe impact of in vivo-like microfluidic flow and the influence of gemini surfactants on amyloid aggregation of hen egg white lysozyme. RSC advances, 2017. 7(18): p. 10973-10984.